Observational studyBMC cancer2019

Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy.

Mark Laible et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.